Re-evaluating the National Subarachnoid Haemorrhage study (2006) from a Patient-Related-Outcome-Measure perspective: Comparing fiscal outcomes of Treatment-as-Usual with an enhanced service
Authors: Pritchard, C., Lindsay, K., Cox, M. and Foulkes, L.
Journal: British Journal of Neurosurgery
Volume: 25
Issue: 3
Pages: 376-383
eISSN: 1360-046X
ISSN: 0268-8697
DOI: 10.3109/02688697.2011.566379
Abstract:Background. Subarachnoid haemorrhage (SAH) is neurological catastrophe, creating major disruption for patient and family, hence the importance of considering Patient-Related-Outcome-Measures (PROM). This study uses the National Study of SAH (2006) to explore any fiscal benefits to patients and NHS if they had an enhanced Neuro-Vascular-Specialist-Nurse (NVSN) service compared to Treatment-as-Usual (TAU). Method. Ensuring total confidentiality, clinical data from the National Study (n = 2397) were matched with regional clinical data of a TAU (n = 137) and prospective NVSN service (n = 184) patients. The TAU and NVSN fiscal outcomes were projected onto the National Study patients to provide estimates of the potential benefits that could accrue nationally from a NVSN service based upon length of stay and earlier return to work of patients and carers. Results. There were substantial benefits for NVSN cohort related to shorter time in hospital, reduced family disruption, earlier return to work and fiscal benefits to family and the NHS. NVSN patients and carers potential savings were estimated at £ 8.097 million and £ 2.492 million to the service, £ 10.497 million overall. Practice implications. This PROM approach allows the 'patient's voice' to be heard, which facilitates speedier patient and family recovery, showing that an integrated treatment approach in 'high tech' neuro-surgery is cost-effective. © 2011 The Neurosurgical Foundation.
Source: Scopus
Re-evaluating the National Subarachnoid Haemorrhage study (2006) from a Patient-Related-Outcome-Measure perspective: comparing fiscal outcomes of Treatment-as-Usual with an enhanced service.
Authors: Pritchard, C., Lindsay, K., Cox, M. and Foulkes, L.
Journal: Br J Neurosurg
Volume: 25
Issue: 3
Pages: 376-383
eISSN: 1360-046X
DOI: 10.3109/02688697.2011.566379
Abstract:BACKGROUND: Subarachnoid haemorrhage (SAH) is neurological catastrophe, creating major disruption for patient and family, hence the importance of considering Patient-Related-Outcome-Measures (PROM). This study uses the National Study of SAH (2006) to explore any fiscal benefits to patients and NHS if they had an enhanced Neuro-Vascular-Specialist-Nurse (NVSN) service compared to Treatment-as-Usual (TAU). METHOD: Ensuring total confidentiality, clinical data from the National Study (n=2397) were matched with regional clinical data of a TAU (n=137) and prospective NVSN service (n=184) patients. The TAU and NVSN fiscal outcomes were projected onto the National Study patients to provide estimates of the potential benefits that could accrue nationally from a NVSN service based upon length of stay and earlier return to work of patients and carers. RESULTS: There were substantial benefits for NVSN cohort related to shorter time in hospital, reduced family disruption, earlier return to work and fiscal benefits to family and the NHS. NVSN patients and carers potential savings were estimated at £ 8.097 million and £ 2.492 million to the service, £ 10.497 million overall. PRACTICE IMPLICATIONS: This PROM approach allows the 'patient's voice' to be heard, which facilitates speedier patient and family recovery, showing that an integrated treatment approach in 'high tech' neuro-surgery is cost-effective.
Source: PubMed
Re-evaluating the National Subarachnoid Haemorrhage study (2006) from a Patient-Related-Outcome-Measure perspective: comparing fiscal outcomes of Treatment-as-Usual with an enhanced service
Authors: Pritchard, C., Lindsay, K., Cox, M. and Foulkes, L.
Journal: BRITISH JOURNAL OF NEUROSURGERY
Volume: 25
Issue: 3
Pages: 376-383
eISSN: 1360-046X
ISSN: 0268-8697
DOI: 10.3109/02688697.2011.566379
Source: Web of Science (Lite)
Re-evaluating the National Subarchnoid Haemorrhage study (2006) from a patient-related-Outcome-Measure perspective: comparing fiscal outcomes of Treatment-as-Usual with an enhanced service
Authors: Pritchard, C., Lindsay, K., Cox, M. and Foulkes, L.M.
Journal: British Journal of Neurosurgery
Volume: 25
Pages: 376-383
ISSN: 0268-8697
DOI: 10.3109/02688697.2011.566379
Source: Manual
Re-evaluating the National Subarachnoid Haemorrhage study (2006) from a Patient-Related-Outcome-Measure perspective: comparing fiscal outcomes of Treatment-as-Usual with an enhanced service.
Authors: Pritchard, C., Lindsay, K., Cox, M. and Foulkes, L.
Journal: British journal of neurosurgery
Volume: 25
Issue: 3
Pages: 376-383
eISSN: 1360-046X
ISSN: 0268-8697
DOI: 10.3109/02688697.2011.566379
Abstract:Background
Subarachnoid haemorrhage (SAH) is neurological catastrophe, creating major disruption for patient and family, hence the importance of considering Patient-Related-Outcome-Measures (PROM). This study uses the National Study of SAH (2006) to explore any fiscal benefits to patients and NHS if they had an enhanced Neuro-Vascular-Specialist-Nurse (NVSN) service compared to Treatment-as-Usual (TAU).Method
Ensuring total confidentiality, clinical data from the National Study (n=2397) were matched with regional clinical data of a TAU (n=137) and prospective NVSN service (n=184) patients. The TAU and NVSN fiscal outcomes were projected onto the National Study patients to provide estimates of the potential benefits that could accrue nationally from a NVSN service based upon length of stay and earlier return to work of patients and carers.Results
There were substantial benefits for NVSN cohort related to shorter time in hospital, reduced family disruption, earlier return to work and fiscal benefits to family and the NHS. NVSN patients and carers potential savings were estimated at £ 8.097 million and £ 2.492 million to the service, £ 10.497 million overall.Practice implications
This PROM approach allows the 'patient's voice' to be heard, which facilitates speedier patient and family recovery, showing that an integrated treatment approach in 'high tech' neuro-surgery is cost-effective.Source: Europe PubMed Central